The Hill equation: a review of its capabilities in pharmacological modelling

被引:622
作者
Goutelle, Sylvain [1 ,2 ,3 ]
Maurin, Michel [4 ]
Rougier, Florent [3 ]
Barbaut, Xavier [3 ]
Bourguignon, Laurent [1 ,2 ,3 ]
Ducher, Michel [3 ]
Maire, Pascal [1 ,2 ,3 ]
机构
[1] Univ Lyon 1, F-69003 Lyon, France
[2] CNRS, UMR Biometrie & Biol Evolut 5558, F-69622 Villeurbanne, France
[3] Hop Antoine Charial, Hosp Civils Lyon, ADCAPT Serv Pharmaceut, F-69340 Francheville, France
[4] Inst Natl Rech Transports & Secur INRETS, F-69500 Bron, France
关键词
curve-fitting; equation; law of mass action; nonlinear modelling; probability distribution;
D O I
10.1111/j.1472-8206.2008.00633.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The Hill equation was first introduced by A.V. Hill to describe the equilibrium relationship between oxygen tension and the saturation of haemoglobin. In pharmacology, the Hill equation has been extensively used to analyse quantitative drug-receptor relationships. Many pharmacokinetic-pharmacodynamic models have used the Hill equation to describe nonlinear drug dose-response relationships. Although the Hill equation is widely used, its many properties are not all well known. This article aims at reviewing the various properties of the Hill equation. The descriptive aspects of the Hill equation, in particular mathematical and graphical properties, are examined, and related to Hill's original work. The mechanistic aspect of the Hill equation, involving a strong connection with the Guldberg and Waage law of mass action, is also described. Finally, a probabilistic view of the Hill equation is examined. Here, we provide some new calculation results, such as Fisher information and Shannon entropy, and we introduce multivariate probabilistic Hill equations. The main features and potential applications of this probabilistic approach are also discussed. Thus, within the same formalism, the Hill equation has many different properties which can be of great interest for those interested in mathematical modelling in pharmacology and biosciences.
引用
收藏
页码:633 / 648
页数:16
相关论文
共 57 条
[1]  
[Anonymous], 1985, Goodman and Gilman's the pharmacological basis of therapeutics
[2]  
[Anonymous], 1910, J. Physiol., DOI [DOI 10.1017/CBO9781107415324.004, DOI 10.1113/JPHYSIOL.1910.SP001386]
[3]  
ARIENS EJ, 1954, ARCH INT PHARMACOD T, V99, P32
[4]   The method of probits [J].
Bliss, C. I. .
SCIENCE, 1934, 79 (2037) :38-39
[5]   G-proteins and GPCRs: From the beginning [J].
Bourne, H. R. .
GPCRS: FROM DEORPHANIZATION TO LEAD STRUCTURE IDENTIFICATION, 2007, 2 :1-21
[6]  
Bouvier d'Yvoire MJY, 1996, CLIN DRUG INVEST, V11, P229
[7]   Cumulative frequency functions [J].
Burr, IW .
ANNALS OF MATHEMATICAL STATISTICS, 1942, 13 :215-232
[8]   DERIVATION AND PROPERTIES OF MICHAELIS-MENTEN TYPE AND HILL TYPE EQUATIONS FOR REFERENCE LIGANDS [J].
CHOU, TC .
JOURNAL OF THEORETICAL BIOLOGY, 1976, 59 (02) :253-276
[9]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[10]   Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies [J].
Chou, Ting-Chao .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :621-681